Norman D. Schwartz 13D and 13G filings for Bio-Rad Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 4:36 pm Purchase | 2025-09-25 | 13D | BIO-RAD LABS BIO | Norman D. Schwartz | 4,929,036 97.200% | 1,700,114 (+52.65%) | Filing |
| 2025-10-30 4:35 pm Sale | 2025-09-25 | 13D | BIO-RAD LABS BIO | Norman D. Schwartz | 3,228,922 14.600% | -1,700,114 (-34.49%) | Filing |
| 2025-10-28 4:30 pm Purchase | 2025-09-25 | 13D | BIO-RAD LABS BIO | Norman D. Schwartz | 4,929,036 97.200% | 1,700,114 (+52.65%) | Filing |
| 2025-10-28 4:30 pm Sale | 2025-09-25 | 13D | BIO-RAD LABS BIO | Norman D. Schwartz | 3,228,922 14.600% | -1,293,760 (-28.61%) | Filing |